Data driven discovery and AI are redefining timelines for drug development. Three days in Basel gather vendors and R&D teams focused on applying data science to discovery and clinical research.
Dates and venue in Basel
Biodata World Congress 2026 runs from 6 to 8 October 2026 in Basel. The event takes place at Basel Fairground, referred to in event materials as Messe Basel, combining conference stages and an exhibition hall across three days.
Key figures for 2026
The 2026 edition shows a broad scale of participation with 3,000 attendees and more than 150 exhibitors. The program features 400 plus speakers and three days of structured activity aimed at life science companies, data providers and investors.
Sectors and company profiles on site
Expect a mix of bioinformatics vendors, genomics platforms, drug discovery companies and pharma R&D teams. Startups in biotech, data-focused solution providers and AI vendors for healthcare are prominent among exhibitors and sponsors.
Program structure and highlighted hubs
Conference tracks cover diagnostics, precision medicine and digital transformation in pharma development. The event includes dedicated hubs such as Healthcare 4.0 Hub, Discovery Disrupted Hub and Data Unleashed Hub. Speakers like Manuela Maronati and Dave Drodge illustrate the intersection of clinical strategy, asset development and digital change.
Commercial prospecting and networking tactics for exhibitors
- Lock meetings in the event platform before arrival. Use the 1‑2‑1 scheduling tools to prioritize buyers and partners.
- Present measurable case studies. Short, metric‑driven use cases on trial acceleration or diagnostic performance resonate with decision makers.
- Showcase integration pathways. Demonstrate how your solution connects to existing data infrastructures and the expected timelines for deployment.
- Define a concise post‑event follow up plan with checkpoints at one and four weeks to move from conversation to pilot.
How to approach the exhibition floor and startups
With 150 plus exhibitors and a strong startup presence, combine booth demos with prearranged meetings. Target technical leads from pharma and teams handling data adoption to accelerate qualification for pilots or proofs of concept.
Closing note and next steps
The prominence of data and AI across tracks and hubs confirms where budgets and pilot projects concentrate in 2026. If your solution targets genomic analysis, clinical data management or machine learning for discovery, align messaging to deployment outcomes and interoperability. Tickets, sponsorship options and meeting tools are listed on the official site http://www.terrapinn.com/conference/biodata/index.stm where you can also apply for exhibition or speaking opportunities.
